Skip to content
10-K

Annual Report

RETINALGENIX TECHNOLOGIES INC. RTGN

0001493152-26-016638

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 15, 2026 18.75M sh
Shares Diluted FY 2025 · Dec 31, 2025 18.56M sh
Shares Diluted FY 2025 · Dec 31, 2024 17.94M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$558.35K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$741.94K
Stockholders Equity FY 2025 · Dec 31, 2025 −$2.3M
Stockholders Equity FY 2025 · Dec 31, 2024 −$1.46M
Stockholders Equity FY 2025 · Dec 31, 2023 −$1.41M
Current Liabilities FY 2025 · Dec 31, 2025 $2.32M
Current Liabilities FY 2025 · Dec 31, 2024 $1.47M
Total Liabilities FY 2025 · Dec 31, 2025 $2.32M
Total Liabilities FY 2025 · Dec 31, 2024 $1.48M
Current Assets FY 2025 · Dec 31, 2025 $14.77K
Current Assets FY 2025 · Dec 31, 2024 $6.06K
Total Assets FY 2025 · Dec 31, 2025 $21.04K
Total Assets FY 2025 · Dec 31, 2024 $14.95K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.13
Eps Diluted FY 2025 · Dec 31, 2024 −$0.24
Eps Basic FY 2025 · Dec 31, 2025 −$0.13
Eps Basic FY 2025 · Dec 31, 2024 −$0.24
Sga Expense FY 2025 · Dec 31, 2025 $1.3M
Sga Expense FY 2025 · Dec 31, 2024 $1.33M
Rd Expense FY 2025 · Dec 31, 2025 $83.04K
Rd Expense FY 2025 · Dec 31, 2024 $373.27K
Net Income FY 2025 · Dec 31, 2025 −$2.43M
Net Income FY 2025 · Dec 31, 2024 −$4.32M